Cite
High level of adherence to osteoporosis prophylaxis medications in steroid-treated polymyalgia rheumatica (pmr)/giant cell arteritis (gca) patients
MLA
Amir Emamifar, et al. High Level of Adherence to Osteoporosis Prophylaxis Medications in Steroid-Treated Polymyalgia Rheumatica (Pmr)/Giant Cell Arteritis (Gca) Patients. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..37cac31b070e7715712f8fbfef74e6aa&authtype=sso&custid=ns315887. Accessed 11 Nov. 2024.
APA
Amir Emamifar, Torkell Ellingsen, Anne Pernille Hermann, Søren Hess, Inger Marie Jensen Hansen, & Peter Thye-Rønn. (n.d.). High level of adherence to osteoporosis prophylaxis medications in steroid-treated polymyalgia rheumatica (pmr)/giant cell arteritis (gca) patients.
Chicago
Amir Emamifar, Torkell Ellingsen, Anne Pernille Hermann, Søren Hess, Inger Marie Jensen Hansen, and Peter Thye-Rønn. 2024. “High Level of Adherence to Osteoporosis Prophylaxis Medications in Steroid-Treated Polymyalgia Rheumatica (Pmr)/Giant Cell Arteritis (Gca) Patients.” Accessed November 11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..37cac31b070e7715712f8fbfef74e6aa&authtype=sso&custid=ns315887.